Tag: Neuromod
Saluda, Neuromod, Neuvotion secure funding rounds to boost neuromodulation technologies
This week, three companies developing novel neuromodulation technologies for use in the treatment of various neurological disorders have each separately announced the receipt of...
Neuromod gains US FDA approval for bimodal neuromodulation tinnitus treatment
Neuromod Devices has announced that the US Food and Drug Administration (FDA) has granted de novo approval to Lenire—the first bimodal neuromodulation device of its kind...
Neuromod publishes new data showing improvement of tinnitus symptoms with bimodal...
Neuromod Devices has published the results of the company's TENT-A2 (Treatment evaluation of neuromodulation for tinnitus—stage A2) clinical trial in Scientific Reports via a...
Neuromod welcomes study demonstrating safety and efficacy of Lenire device in...
Neuromod Devices has welcomed the findings of an independent study performed at the German Hearing Center at Hannover Medical School (Hannover, Germany), which found...
Neuromod Devices appoints Diarmuid Flavin as COO to boost expansion of...
Neuromod Devices has announced the appointment of Diarmuid Flavin as chief operating officer (COO). Flavin brings more than 25 years of global leadership experience...
Neuromod closes €10.5 million financing for Tinnitus treatment device
Neuromod has secured a series B €10.5 million financing for its Lenire tinnitus treatment device. This funding follows the publication of the company’s first...
Bimodal neuromodulation can significantly reduce tinnitus symptoms, new trial finds
Neuromod has announced the publication of the results of a clinical trial which has shown bimodal neuromodulation combining sound and electrical stimulation of the...
Neuromod prepares for global commercialisation of Lenire tinnitus treatment
Neuromod Devices, the Irish medical technology company specialising in non-invasive neuromodulation technologies, has provided an update on organisational and leadership growth in preparation for...
Christopher M Smith joins Neuromod Board as strategic advisor
Neuromod Devices Limited (“Neuromod”), an Irish medical technology company specialising in non-invasive neuromodulation technologies, has announced that Christopher M Smith became Strategic Advisor to...
